Wall Street Analysts Think Jazz Could Surge 44.37 percent Read This Before Placing a Bet

JAZZ Stock  USD 120.56  3.20  2.59%   
Slightly above 75% of Jazz Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Jazz Pharmaceuticals PLC stock suggests that many investors are alarmed at this time. Jazz Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Jazz Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
The consensus price target hints at a 44.4 percent upside potential for Jazz . While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Read at zacks.com
zacks News
  

Jazz Pharmaceuticals PLC Current Investor Sentiment

Panic Vs Confidence

25

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Jazz Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Jazz Pharmaceuticals PLC.

Jazz Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Jazz Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Jazz Pharmaceuticals PLC Historical Investor Sentiment

Investor biases related to Jazz Pharmaceuticals' public news can be used to forecast risks associated with an investment in Jazz. The trend in average sentiment can be used to explain how an investor holding Jazz can time the market purely based on public headlines and social activities around Jazz Pharmaceuticals PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Jazz Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Jazz Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Jazz Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Jazz Pharmaceuticals.

Jazz Pharmaceuticals Maximum Pain Price Across January 17th 2025 Option Contracts

Jazz Pharmaceuticals' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Jazz Pharmaceuticals close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Jazz Pharmaceuticals' options.

Jazz Pharmaceuticals Fundamental Analysis

We analyze Jazz Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jazz Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jazz Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Earning

Price To Earning Comparative Analysis

Jazz Pharmaceuticals is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Jazz Pharmaceuticals PLC Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jazz Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Jazz Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Jazz Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Jazz Pharmaceuticals Related Equities

INBXInhibrx   5.90   
0%
100.0%
LRMRLarimar Therapeutics   4.24   
0%
71.0%
TECHBio Techne   3.23   
0%
54.0%
LEGNLegend Biotech   3.02   
0%
51.0%
VRDNViridian Therapeutics   2.18   
0%
36.0%
DNLIDenali Therapeutics   2.02   
0%
34.0%
PCVXVaxcyte   1.87   
0%
31.0%
ASNDAscendis Pharma   1.74   
0%
29.0%
LQDALiquidia Technologies   1.57   
0%
26.0%
PTGXProtagonist Therapeutics   1.51   
0%
25.0%
BPMCBlueprint Medicines   1.32   
0%
22.0%
APLSApellis Pharmaceuticals   0.90   
0%
15.0%
RAREUltragenyx   0.85   
0%
14.0%
BMRNBiomarin Pharmaceutical   0.51   
0%
8.0%
ALNYAlnylam Pharmaceuticals   0.28   
0%
4.0%
ARGXArgenx NV   0.18   
0%
3.0%
INCYIncyte   0.14   
0%
2.0%
EXELExelixis   0.09   
0%
1.0%
HALOHalozyme Therapeutics   0.56   
9.0%
0%
UTHRUnited Therapeutics   1.08   
18.0%
0%

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.